[ad_1]
Researchers at the Tata Institute in Mumbai announced the development of a new drug aimed at preventing cancer recurrence, according to a report in Hindustan Times. Researchers and doctors at the institute worked for 10 years and have now created a tablet that they claim would stop cancer from appearing in patients for the second time.
The tablet is priced at $100 per piece, depending on Business standard.
Read also | YoIT-Madras researchers patent use of Indian spices to treat cancer; drugs likely to be available in 2028
“We did a small experiment where we took human breast cancer cells and implanted them into immunodeficient mice,” said Dr. Indraneel Mittra, the oncosurgeon-turned-scientist who led TMH doctors in the study, as quoted by Hindustan Times. “In six weeks a small tumor formed. We divided the mice into three categories based on cancer treatment: chemotherapy, radiotherapy and surgery. “We found that all three treatments increased chromatin in the mouse brain.”
Read also | Prince Harry ‘outraged’ Queen Camilla and was ‘asked to leave’ during his visit to King Charles, who is suffering from cancer.
“We found that a combination of resveratrol and copper helped destroy chromatin. “We used the combination orally in our studies and found that it prevented metastasis,” said Dr. Mittra, adding that while this was the result of the experiment in mice, the team would now do tests in humans, according to the H.T. report. Dr. Mittra joined TMH in 1982 as the country’s first “surgeon-scientist.”
Read also | These pharmaceutical companies go nuclear to fight cancer
Mittra further explained that after confirming the presence of chromatin particles after cancer treatment, the team’s focus was on reducing treatment-related toxicity (side effects) in various human cancers, such as stomach, brain, oral and blood through clinical trials, such as Hindustan Times report.
Unlock a world of benefits! From informative newscasts to real-time stock tracking, breaking news and a personalized newsfeed – it’s all here, just a click away! Sign in now!